February 1, 2024 · Form 4 insider transaction
Rotman Harris bought 75,000 shares of CENTESSA PHARMACEUTICALS PLC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.